m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00140)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
NEAT1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 14 (METTL14) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL14 | ||
Cell Line | MDA-MB-231 | Homo sapiens |
Treatment: siMETTL14 MDA-MB-231 cells
Control: MDA-MB-231 cells
|
GSE81164 | |
Regulation |
|
logFC: -8.94E-01 p-value: 3.90E-11 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | In renal cell carcinoma, YTHDF2 accelerated the degradation of Nuclear paraspeckle assembly transcript 1 (NEAT1)_1 by selectively recognizing METTL14-mediated m6A marks on Nuclear paraspeckle assembly transcript 1 (NEAT1)_1. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Renal cell carcinoma | ICD-11: 2C90 | ||
Cell Process | Cell proliferation and metastasis | |||
In-vitro Model | 769-P | Renal cell carcinoma | Homo sapiens | CVCL_1050 |
786-O | Renal cell carcinoma | Homo sapiens | CVCL_1051 | |
HK2 | Normal | Acipenser baerii | CVCL_YE28 | |
In-vivo Model | Mouse subcutaneous xenograft and lung metastasis experiments were carried out with six 4-week-old male BALB/c nude mice. | |||
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | LX2 cell line | Homo sapiens |
Treatment: shMETTL3 LX2 cells
Control: shLuc LX2 cells
|
GSE207909 | |
Regulation |
|
logFC: 1.39E+00 p-value: 3.32E-29 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [2] | |||
Response Summary | METTL3-mediated m6A modification induced the aberrant expression of Nuclear paraspeckle assembly transcript 1 (NEAT1) in chronic myelocytic leukemia. Overexpression of NEAT1 inhibited cell viability and promoted the apoptosis of chronic myelocytic leukemia cells. miR-766-5p was upregulated in CML PBMCs and abrogated the effects of NEAT1 on cell viability and apoptosis of the chronic myelocytic leukemia cells. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Chronic myeloid leukaemia | ICD-11: 2B33.2 | ||
Cell Process | Cell viability and apoptosis | |||
In-vitro Model | BV-173 | Chronic myelogenous leukemia | Homo sapiens | CVCL_0181 |
K-562 | Chronic myelogenous leukemia | Homo sapiens | CVCL_0004 | |
KCL-22 | Chronic myelogenous leukemia | Homo sapiens | CVCL_2091 | |
MEG-01 | Chronic myelogenous leukemia | Homo sapiens | CVCL_0425 | |
RNA demethylase ALKBH5 (ALKBH5) [ERASER]
Representative RNA-seq result indicating the expression of this target gene regulated by ALKBH5 | ||
Cell Line | HaCAT cell line | Homo sapiens |
Treatment: siALKBH5 HaCAT cells
Control: siControl HaCAT cells
|
GSE211076 | |
Regulation |
|
logFC: -6.88E-01 p-value: 8.40E-87 |
More Results | Click to View More RNA-seq Results |
In total 5 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [3] | |||
Response Summary | Hypoxia-induced ALKBH5 erased m6A deposition from the lncRNA NEAT1, stabilizing the transcript and facilitating Nuclear paraspeckle assembly transcript 1 (NEAT1)-mediated paraspeckle assembly. Ectopic expression of CXCL8 in ALKBH5-deficient glioblastoma multiforme cells partially restored TAM recruitment and tumor progression. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Glioblastoma | ICD-11: 2A00.00 | ||
Pathway Response | Transcriptional misregulation in cancer | hsa05202 | ||
Cell Process | Immune | |||
In-vitro Model | GL261 | Mouse glioblastoma | Mus musculus | CVCL_Y003 |
U87 (A primary glioblastoma cell line) | ||||
In-vivo Model | Male C57BL/6 mice (4-6 weeks old) were used in all tumor allografting experiments and transplanted with GL261-luc cells (1×105) into the frontal lobes of brains. | |||
Experiment 2 Reporting the m6A Methylation Regulator of This Target Gene | [4] | |||
Response Summary | ALKBH5 promotes Gastric cancer invasion and metastasis by demethylating the lncRNA Nuclear paraspeckle assembly transcript 1 (NEAT1). | |||
Target Regulation | Up regulation | |||
Responsed Disease | Gastric cancer | ICD-11: 2B72 | ||
Cell Process | Cell proliferation and metastasis | |||
In-vitro Model | BGC-823 | Gastric carcinoma | Homo sapiens | CVCL_3360 |
GES-1 | Normal | Homo sapiens | CVCL_EQ22 | |
SGC-7901 | Gastric carcinoma | Homo sapiens | CVCL_0520 | |
Experiment 3 Reporting the m6A Methylation Regulator of This Target Gene | [5] | |||
Response Summary | ALKBH5 knockdown suppressed malignant behavior of colon cancer partially through Nuclear paraspeckle assembly transcript 1 (NEAT1) by demethylation in vitro and vivo, suggesting that ALKBH5-NEAT1 axis is a potential therapeutic target for colon cancer treatment. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Colorectal cancer | ICD-11: 2B91 | ||
Cell Process | Cell proliferation and migration | |||
Cell apoptosis | ||||
In-vitro Model | HCT 8 | Colon adenocarcinoma | Homo sapiens | CVCL_2478 |
HIEC (Normal intestinal epithelial cells) | ||||
LoVo | Colon adenocarcinoma | Homo sapiens | CVCL_0399 | |
RKO | Colon carcinoma | Homo sapiens | CVCL_0504 | |
SW620 | Colon adenocarcinoma | Homo sapiens | CVCL_0547 | |
In-vivo Model | To establish xenograft model, RKO cells (1 × 107) tansduced with si-control (si-NC) or si-ALKBH5 or si-ALKBH5+NEAT1 were injected subcutaneously into the right flank of the nude mice (n = 6 each group) every 5 days for 4 times. | |||
Experiment 4 Reporting the m6A Methylation Regulator of This Target Gene | [6] | |||
Response Summary | ALKBH5 could up-regulate Nuclear paraspeckle assembly transcript 1 (NEAT1) expression by inhibiting m6A enrichment. ALKBH5-induced NEAT1 promoted cell proliferation and migration of HCC by sponging miR-214 in vitro, which provided a potential therapeutic target for HCC. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12.02 | ||
Cell Process | Cell proliferation and migration | |||
Cell apoptosis | ||||
In-vitro Model | SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 |
L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
Experiment 5 Reporting the m6A Methylation Regulator of This Target Gene | [7] | |||
Response Summary | ALKBH5 knockdown suppressed cell proliferation, migration and invasion of infantile hemangioma cells, while promoting cell apoptosis. ALKBH5 promoted lncRNA Nuclear paraspeckle assembly transcript 1 (NEAT1) expression by reducing the m6A modification of lncRNA NEAT1. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Infantile hemangioma | ICD-11: 2E+81 | ||
Cell Process | Cell proliferation | |||
Cell migration | ||||
Cell invasion | ||||
Cell apoptosis | ||||
In-vitro Model | XPTS-1 | Infantile hemangioma | Homo sapiens | CVCL_9U60 |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
YTH domain-containing family protein 2 (YTHDF2) [READER]
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | In renal cell carcinoma, YTHDF2 accelerated the degradation of Nuclear paraspeckle assembly transcript 1 (NEAT1)_1 by selectively recognizing METTL14-mediated m6A marks on Nuclear paraspeckle assembly transcript 1 (NEAT1)_1. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Renal cell carcinoma | ICD-11: 2C90 | ||
Cell Process | Cell proliferation and metastasis | |||
In-vitro Model | 769-P | Renal cell carcinoma | Homo sapiens | CVCL_1050 |
786-O | Renal cell carcinoma | Homo sapiens | CVCL_1051 | |
HK2 | Normal | Acipenser baerii | CVCL_YE28 | |
In-vivo Model | Mouse subcutaneous xenograft and lung metastasis experiments were carried out with six 4-week-old male BALB/c nude mice. | |||
Brain cancer [ICD-11: 2A00]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [3] | |||
Response Summary | Hypoxia-induced ALKBH5 erased m6A deposition from the lncRNA NEAT1, stabilizing the transcript and facilitating Nuclear paraspeckle assembly transcript 1 (NEAT1)-mediated paraspeckle assembly. Ectopic expression of CXCL8 in ALKBH5-deficient glioblastoma multiforme cells partially restored TAM recruitment and tumor progression. | |||
Responsed Disease | Glioblastoma [ICD-11: 2A00.00] | |||
Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
Target Regulation | Down regulation | |||
Pathway Response | Transcriptional misregulation in cancer | hsa05202 | ||
Cell Process | Immune | |||
In-vitro Model | GL261 | Mouse glioblastoma | Mus musculus | CVCL_Y003 |
U87 (A primary glioblastoma cell line) | ||||
In-vivo Model | Male C57BL/6 mice (4-6 weeks old) were used in all tumor allografting experiments and transplanted with GL261-luc cells (1×105) into the frontal lobes of brains. | |||
Malignant haematopoietic neoplasm [ICD-11: 2B33]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [2] | |||
Response Summary | METTL3-mediated m6A modification induced the aberrant expression of Nuclear paraspeckle assembly transcript 1 (NEAT1) in chronic myelocytic leukemia. Overexpression of NEAT1 inhibited cell viability and promoted the apoptosis of chronic myelocytic leukemia cells. miR-766-5p was upregulated in CML PBMCs and abrogated the effects of NEAT1 on cell viability and apoptosis of the chronic myelocytic leukemia cells. | |||
Responsed Disease | Chronic myeloid leukaemia [ICD-11: 2B33.2] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
Cell Process | Cell viability and apoptosis | |||
In-vitro Model | BV-173 | Chronic myelogenous leukemia | Homo sapiens | CVCL_0181 |
K-562 | Chronic myelogenous leukemia | Homo sapiens | CVCL_0004 | |
KCL-22 | Chronic myelogenous leukemia | Homo sapiens | CVCL_2091 | |
MEG-01 | Chronic myelogenous leukemia | Homo sapiens | CVCL_0425 | |
Gastric cancer [ICD-11: 2B72]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [4] | |||
Response Summary | ALKBH5 promotes Gastric cancer invasion and metastasis by demethylating the lncRNA Nuclear paraspeckle assembly transcript 1 (NEAT1). | |||
Responsed Disease | Gastric cancer [ICD-11: 2B72] | |||
Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
Target Regulation | Up regulation | |||
Cell Process | Cell proliferation and metastasis | |||
In-vitro Model | BGC-823 | Gastric carcinoma | Homo sapiens | CVCL_3360 |
GES-1 | Normal | Homo sapiens | CVCL_EQ22 | |
SGC-7901 | Gastric carcinoma | Homo sapiens | CVCL_0520 | |
Colorectal cancer [ICD-11: 2B91]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [5] | |||
Response Summary | ALKBH5 knockdown suppressed malignant behavior of colon cancer partially through Nuclear paraspeckle assembly transcript 1 (NEAT1) by demethylation in vitro and vivo, suggesting that ALKBH5-NEAT1 axis is a potential therapeutic target for colon cancer treatment. | |||
Responsed Disease | Colorectal cancer [ICD-11: 2B91] | |||
Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
Target Regulation | Up regulation | |||
Cell Process | Cell proliferation and migration | |||
Cell apoptosis | ||||
In-vitro Model | HCT 8 | Colon adenocarcinoma | Homo sapiens | CVCL_2478 |
HIEC (Normal intestinal epithelial cells) | ||||
LoVo | Colon adenocarcinoma | Homo sapiens | CVCL_0399 | |
RKO | Colon carcinoma | Homo sapiens | CVCL_0504 | |
SW620 | Colon adenocarcinoma | Homo sapiens | CVCL_0547 | |
In-vivo Model | To establish xenograft model, RKO cells (1 × 107) tansduced with si-control (si-NC) or si-ALKBH5 or si-ALKBH5+NEAT1 were injected subcutaneously into the right flank of the nude mice (n = 6 each group) every 5 days for 4 times. | |||
Liver cancer [ICD-11: 2C12]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [6] | |||
Response Summary | ALKBH5 could up-regulate Nuclear paraspeckle assembly transcript 1 (NEAT1) expression by inhibiting m6A enrichment. ALKBH5-induced NEAT1 promoted cell proliferation and migration of HCC by sponging miR-214 in vitro, which provided a potential therapeutic target for HCC. | |||
Responsed Disease | Hepatocellular carcinoma [ICD-11: 2C12.02] | |||
Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
Target Regulation | Up regulation | |||
Cell Process | Cell proliferation and migration | |||
Cell apoptosis | ||||
In-vitro Model | SMMC-7721 | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 |
L-02 | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | |
Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 | |
Renal cell carcinoma [ICD-11: 2C90]
In total 2 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | In renal cell carcinoma, YTHDF2 accelerated the degradation of Nuclear paraspeckle assembly transcript 1 (NEAT1)_1 by selectively recognizing METTL14-mediated m6A marks on Nuclear paraspeckle assembly transcript 1 (NEAT1)_1. | |||
Responsed Disease | Renal cell carcinoma [ICD-11: 2C90] | |||
Target Regulator | Methyltransferase-like 14 (METTL14) | WRITER | ||
Target Regulation | Down regulation | |||
Cell Process | Cell proliferation and metastasis | |||
In-vitro Model | 769-P | Renal cell carcinoma | Homo sapiens | CVCL_1050 |
786-O | Renal cell carcinoma | Homo sapiens | CVCL_1051 | |
HK2 | Normal | Acipenser baerii | CVCL_YE28 | |
In-vivo Model | Mouse subcutaneous xenograft and lung metastasis experiments were carried out with six 4-week-old male BALB/c nude mice. | |||
Experiment 2 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | In renal cell carcinoma, YTHDF2 accelerated the degradation of Nuclear paraspeckle assembly transcript 1 (NEAT1)_1 by selectively recognizing METTL14-mediated m6A marks on Nuclear paraspeckle assembly transcript 1 (NEAT1)_1. | |||
Responsed Disease | Renal cell carcinoma [ICD-11: 2C90] | |||
Target Regulator | YTH domain-containing family protein 2 (YTHDF2) | READER | ||
Target Regulation | Down regulation | |||
Cell Process | Cell proliferation and metastasis | |||
In-vitro Model | 769-P | Renal cell carcinoma | Homo sapiens | CVCL_1050 |
786-O | Renal cell carcinoma | Homo sapiens | CVCL_1051 | |
HK2 | Normal | Acipenser baerii | CVCL_YE28 | |
In-vivo Model | Mouse subcutaneous xenograft and lung metastasis experiments were carried out with six 4-week-old male BALB/c nude mice. | |||
Infantile hemangioma [ICD-11: 2E81]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [7] | |||
Response Summary | ALKBH5 knockdown suppressed cell proliferation, migration and invasion of infantile hemangioma cells, while promoting cell apoptosis. ALKBH5 promoted lncRNA Nuclear paraspeckle assembly transcript 1 (NEAT1) expression by reducing the m6A modification of lncRNA NEAT1. | |||
Responsed Disease | Infantile hemangioma [ICD-11: 2E+81] | |||
Target Regulator | RNA demethylase ALKBH5 (ALKBH5) | ERASER | ||
Target Regulation | Up regulation | |||
Cell Process | Cell proliferation | |||
Cell migration | ||||
Cell invasion | ||||
Cell apoptosis | ||||
In-vitro Model | XPTS-1 | Infantile hemangioma | Homo sapiens | CVCL_9U60 |
HEK293T | Normal | Homo sapiens | CVCL_0063 | |
References